Elicasal 5%%, 0.1%

Država: Jordanija

Jezik: angleščina

Source: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Aktivna sestavina:

Salicylic Acid 5% %, Mometasone Furoate 0.1 %

Dostopno od:

مستودع ادوية ارض الدواء - Land Of Medicine Drug Store

Koda artikla:

D07XC03

INN (mednarodno ime):

Salicylic Acid 5% %, Mometasone Furoate 0.1 %

Odmerek:

5%%, 0.1%

Enote v paketu:

30 gm

Izdeluje:

JAMJOOM PHARMACEUTICALS COMPANY/SAUDI ARABIA (السعودية)

Povzetek izdelek:

5.82 :سعر الجمهور + الضريبة

Navodilo za uporabo

COMPOSITION:
Each gram of Elicasal
TM
ointment contains active compound mometasone furoate 1
mg and salicylic acid 50 mg in suitable ointment base.
INDICATIONS:
Mometasone furoate belongs to a group of medicines called
corticosteroids or steroids as they
are simply known. Mometasone is a strongly acting glucocorticoid with
anti- inflammatory and
antipruritic effect.Salicylic acid helps to remove dry and scaling
skin. Salicylic acid also increases
the uptake of mometasone.
Elicasal
TM
is used to treat psoriasis, especially in case of intensive scaling.
DOSAGE AND ADMINISTRATION:
Apply a thin film of Elicasal
TM
to the affected skin areas twice or once daily.
PHARMACOLOGY:
Mometasone
is
a
synthetic
corticosteroid,
exhibits
anti-inflammatory,
antipruritic
and
vasoconstrictive properties. Topical salicylic acid softens Keratin,
loosens cornfield epithelium
and desqunates the epidermis.
PRECAUTION:
Avoid ointment on eyes or on mucous membranes. Elicasal
TM
is not to be used in the face
without prescription by your doctor. Treatment during longer periods
and on large body surface
areas, on wounds and sounded skin, and in the armpits and groins
should be avoided .The
ointment should not be used under bandages or similar. Glucocorticoids
can mask, trigger or
worsen skin infections.If you develop skin infections while using this
ointment, your doctor will
give you an appropriate treatment for fungal or bacterial infections.
If you do not respond to
treatment, please discontinue
Elicasal
TM
until the infection is under control.Contact your doctor
if irritation, including excessive dryness develops. The treatment
might need to be discontinued
and appropriate therapy instituted. Use of topical corticosteroid in
children should be limited to
the least amount compatible with an effective therapeutic regimen.
Since safe use of mometasone furoate 0.1% in pregnant women has not
been established,
topical corticosteroids should be used during pregnancy only if the
potential benefit justifies
potential risk to the fetus. It is